Published on January 21, 2012 at 1:59 AM
Discussing the recent reports of so-called "totally drug-resistant" tuberculosis (TDR-TB) in India, journalist John Donnelly in this GlobalPost "Global Voices" blog entry writes, "Overall, the world is treating drug-resistant TB extraordinarily poorly, and that creates more and more cases of resistant TB that aren't being cured." Donnelly describes his experience in Peru, where he and photographer Riccardo Venturi recently traveled at the invitation of the Japanese company Otsuka Pharmaceutical and "met with local scientists, doctors and patients to explore the scope of the struggle to fight drug-resistant TB." Donnelly notes during their travel to "look at the human impact of TB and what different innovations in treatment mean for patients" they "are acting independently" (1/19).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.